Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Easterly Government Properties (DEA) Meets Q2 FFO Estimates
Easterly Government Properties (DEA) Meets Q2 FFO Estimates

Easterly Government Properties (DEA) came out with quarterly funds from operations (FFO) of $0.74 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.73 per share a

Caterpillar (CAT) Q2 Earnings Miss Estimates
Caterpillar (CAT) Q2 Earnings Miss Estimates

Caterpillar (CAT) came out with quarterly earnings of $4.72 per share, missing the Zacks Consensus Estimate of $4.88 per share. This compares to earnings of $5.99 per share a year ago. These figures

Will GLP-1 Demand Drive MCK's Top Line This Earnings Season?
Will GLP-1 Demand Drive MCK's Top Line This Earnings Season?

McKesson Corporation MCK is scheduled to report first-quarter fiscal 2026 results on Aug. 6, after market close.

The company delivered an earnings surprise of 3.16% in the last reported quarter. Its

ISRG's Ion Platform Sees Uptick in Utilization, Eyes Efficiency
ISRG's Ion Platform Sees Uptick in Utilization, Eyes Efficiency

Intuitive Surgical’s ISRG Ion platform continues to build momentum, posting a robust 52% year-over-year improvement in procedures (to approximately 35,000) for second-quarter 2025. However, the real

Clear Channel Outdoor (CCO) Reports Q2 Loss, Tops Revenue Estimates
Clear Channel Outdoor (CCO) Reports Q2 Loss, Tops Revenue Estimates

Clear Channel Outdoor (CCO) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.06 per share a year ago. These figures are

Vishay Precision (VPG) Surpasses Q2 Earnings and Revenue Estimates
Vishay Precision (VPG) Surpasses Q2 Earnings and Revenue Estimates

Vishay Precision (VPG) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.31 per share a year ago. These

Oaktree Specialty Lending (OCSL) Q3 Earnings and Revenues Miss Estimates
Oaktree Specialty Lending (OCSL) Q3 Earnings and Revenues Miss Estimates

Oaktree Specialty Lending (OCSL) came out with quarterly earnings of $0.37 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.55 per share a year

Northwest Natural (NWN) Q2 Earnings Surpass Estimates
Northwest Natural (NWN) Q2 Earnings Surpass Estimates

Northwest Natural (NWN) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to a loss of $0.07 per share a year ago

Atkore Inc. (ATKR) Tops Q3 Earnings and Revenue Estimates
Atkore Inc. (ATKR) Tops Q3 Earnings and Revenue Estimates

Atkore Inc. (ATKR) came out with quarterly earnings of $1.63 per share, beating the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $3.8 per share a year ago. These figures

Edgewell Personal Care (EPC) Misses Q3 Earnings and Revenue Estimates
Edgewell Personal Care (EPC) Misses Q3 Earnings and Revenue Estimates

Edgewell Personal Care (EPC) came out with quarterly earnings of $0.92 per share, missing the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.22 per share a year ago

Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates

Esperion Therapeutics (ESPR) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.05 per share a year ago. These

Lemonade (LMND) Reports Q2 Loss, Tops Revenue Estimates
Lemonade (LMND) Reports Q2 Loss, Tops Revenue Estimates

Lemonade (LMND) came out with a quarterly loss of $0.6 per share versus the Zacks Consensus Estimate of a loss of $0.81. This compares to a loss of $0.81 per share a year ago. These figures are

Amneal Pharmaceuticals (AMRX) Q2 Earnings Top EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Amneal Pharmaceuticals (AMRX) Q2 Earnings Top Estimates

Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.16 per share a year ago

Ares Commercial Real Estate (ACRE) Reports Q2 Loss, Lags Revenue Estimates
Ares Commercial Real Estate (ACRE) Reports Q2 Loss, Lags Revenue Estimates

Ares Commercial Real Estate (ACRE) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.12 per share a year ago

Clear Secure (YOU) Q2 Earnings and Revenues Surpass Estimates
Clear Secure (YOU) Q2 Earnings and Revenues Surpass Estimates

Clear Secure (YOU) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.34 per share a year ago. These

Leidos (LDOS) Q2 Earnings and Revenues Top Estimates
Leidos (LDOS) Q2 Earnings and Revenues Top Estimates

Leidos (LDOS) came out with quarterly earnings of $3.21 per share, beating the Zacks Consensus Estimate of $2.63 per share. This compares to earnings of $2.63 per share a year ago. These figures are

Henry Schein (HSIC) Q2 Earnings Lag Estimates
Henry Schein (HSIC) Q2 Earnings Lag Estimates

Henry Schein (HSIC) came out with quarterly earnings of $1.1 per share, missing the Zacks Consensus Estimate of $1.18 per share. This compares to earnings of $1.23 per share a year ago. These

Gartner (IT) Tops Q2 Earnings and Revenue Estimates
Gartner (IT) Tops Q2 Earnings and Revenue Estimates

Gartner (IT) came out with quarterly earnings of $3.53 per share, beating the Zacks Consensus Estimate of $3.38 per share. This compares to earnings of $3.22 per share a year ago. These figures are

Pediatrix Medical Group (MD) Q2 Earnings and Revenues Top EstimatesPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Pediatrix Medical Group (MD) Q2 Earnings and Revenues Top Estimates

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.34 per share a year ago

DuPont de Nemours (DD) Surpasses Q2 Earnings and Revenue Estimates
DuPont de Nemours (DD) Surpasses Q2 Earnings and Revenue Estimates

DuPont de Nemours (DD) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.97 per share a year ago. These

Ball (BALL) Q2 Earnings and Revenues Top Estimates
Ball (BALL) Q2 Earnings and Revenues Top Estimates

Ball (BALL) came out with quarterly earnings of $0.9 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.74 per share a year ago. These figures are

Yum China Holdings (YUMC) Surpasses Q2 Earnings and Revenue Estimates
Yum China Holdings (YUMC) Surpasses Q2 Earnings and Revenue Estimates

Yum China Holdings (YUMC) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.55 per share a year ago. These

DHL Group Sponsored ADR (DHLGY) Q2 Earnings Beat Estimates
DHL Group Sponsored ADR (DHLGY) Q2 Earnings Beat Estimates

DHL Group Sponsored ADR (DHLGY) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.69 per share a year ago

Is PONAX a Strong Bond Fund Right Now?
Is PONAX a Strong Bond Fund Right Now?

On the lookout for a Diversified Bonds fund? Starting with PIMCO Income A (PONAX) is one possibility. PONAX holds a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting

Is BlackRock Science & Technology Opportunities A (BGSAX) a Strong Mutual Fund Pick Right Now?
Is BlackRock Science & Technology Opportunities A (BGSAX) a Strong Mutual Fund Pick Right Now?

There are plenty of choices in the Sector - Tech category, but where should you start your research? Well, one fund that may not be worth investigating is BlackRock Science & Technology